source
- Hims reports $33 million loss after shifting focus to GLP-1 marketHims said its latest earnings were hit by a $33 million charge tied to a strategic shift toward GLP-1 treatments. The charge stems from costs of redirecting product development and marketing resou…
- New sepsis AI models face adoption hurdles despite improved performanceHospitals once embraced an Epic sepsis‑prediction algorithm that promised early alerts for a condition that kills over 350,000 Americans each year. In practice the tool generated far more alerts th…